Missed Druggable Cancer Hallmark: Cancer–Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy

Sverdlov Eugene

首页> 外文期刊>BioEssays : >Missed Druggable Cancer Hallmark: Cancer–Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy

【24h】

Missed Druggable Cancer Hallmark: Cancer–Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy

机译：错过了可毒癌症癌症标志：癌基质共生串扰作为癌症治疗的范式和假设

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《BioEssays :》 |2018年第11期|共10页
作者
Sverdlov Eugene;
展开▼
作者单位

Shemyakin‐Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of SciencesUlitsa Miklukho‐Maklaya 16/10 117997 Moscow Russia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类普通生物学;
关键词
cancer; crosstalk; hallmarks; immunotherapy; stroma; therapy;

机译：癌症;串扰;标志;免疫疗法;基质;治疗;

相似文献

外文文献
中文文献
专利

1. Missed Druggable Cancer Hallmark: Cancer–Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy [J] . Sverdlov Eugene BioEssays : . 2018,第11期

机译：错过了可毒癌症癌症标志：癌基质共生串扰作为癌症治疗的范式和假设
2. New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy [J] . Christian Hafner Albrecht Reichle Thomas Vogt Current Cancer Drug Targets . 2005,第6期

机译：既定药物的新适应症：靶向肿瘤间质的癌症治疗与PPARγ激动剂，COX-2抑制剂，mTOR拮抗剂和节律性化学疗法的结合
3. New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy. [J] . Hafner C, Reichle A, Vogt T Current cancer drug targets . 2005,第6期

机译：既定药物的新迹象：将肿瘤 - 基质靶向癌症治疗组合与PPARGAMMA激动剂，COX-2抑制剂，MTOR拮抗剂和度量组化疗。
4. IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer [C] . Hongyu Zhou, Weiping Qian, Fatih M. Uckun, Conference on Micro- and Nanotechnology Sensors, Systems, and Applications . 2016

机译：IGF-1受体靶向纳米颗粒用于图像诱导治疗富含基质和耐药的人类癌症
5. Targeting the Crosstalk between AR3 and E2F1 as a Prospective Therapy for Drug-Resistant Prostate Cancer [D] . Xu, Jin. 2020

机译：靶向AR3和E2F1之间的串扰作为耐药前列腺癌的前瞻性疗法
6. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers [O] . Jhih-Ying Chi, Yu-Wei Hsiao, Chien-Feng Li, 2015

机译：针对肿瘤基质中化疗诱导的PTX3以预防耐药性癌症的进展
7. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers [O] . Jhih-Ying Chi, Yu-Wei Hsiao, Chien-Feng Li, 2015

机译：靶向化疗诱导的肿瘤基质PTX3，以防止耐药癌的进展

Missed Druggable Cancer Hallmark: Cancer–Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅